Primary Record
Berubicin
- In stock
- 557 g
- Purity
- 98.8 %
- CAS
- 677017-23-1
Compound Identifiers & Properties
- CAS
- 677017-23-1
- PubChem CID
- 9874592
- SMILES
- C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)OCC6=CC=CC=C6
- Canonical SMILES
- COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](OCc2ccccc2)[C@H](C)O1
Names & Synonyms
- Berubicin
- Berubicin [INN]
- berubicina
- berubicine
- berubicinum
- WP 769
- UNII-6QPN83HK2M
- 6QPN83HK2M
- Berubicin hydrochloride
- Berubicin(WP 769)
- Daunorubicin Impurity 9
- 4'O-Benzyl Doxorubicin
- 677017-23-1
- BERUBICIN [WHO-DD]
- RefChem:119102
- Berubicin (oral, cancer)
- D03AZR
- Berubicin;WP-769;WP769
- DTXSID70217986
- CHEMBL2110580
- SCHEMBL29360975
- DTXCID20140477
- RTA-744
- RTA-769
- WP-769
- C34H35NO11
- BBF-04653
- WP-744
- ZINC72267022
- CID9874592
- CID 9874592
- BB178714
- HY-14942
- CS-0003648
- Berubicin (intravenous), Reata Pharmaceuticals
- Berubicin (oral, cancer), Reata Pharmaceuticals
- (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-6-methyl-5-phenylmethoxyoxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
- Q27265347
- Anthracycline derivative topoisomerase II inhibitor (cancer), Reata
- (8S,10S)-10-((3-AMINO-4-O-BENZYL-2,3,6-TRIDEOXY-A-L-LYXO-HEXOPYRANOSYL)OXY)-6,8,11-TRIHYDROXY-8-(HYDROXYACETYL)-1-METHOXY-7,8,9,10-TETRAHYDROTETRACENE-5,12-DIONE
- 5,12-NAPHTHACENEDIONE, 10-((3-AMINO-2,3,6-TRIDEOXY-4-O-(PHENYLMETHYL)-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(HYDROXYACETYL)-1-METHOXY-, (8S,10S)-
- Anthracycline derivative topoisomerase II inhibitor (cancer), MD Anderson
- Anthracycline topoisomerase II inhibitor (oral, cancer), MD Anderson Cancer Center
- Anthracycline topoisomerase II inhibitor (oral, cancer), Reata Pharmaceuticals
- (1S,3S)-3,5,12-Trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-4-O-benzyl-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
- (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-benzyloxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
- 5,12-NAPHTHACENEDIONE, 10-((3-AMINO-2,3,6-TRIDEOXY-4-O-(PHENYLMETHYL)-ALPHA-L-LYXO-HEXOPYRANOSYL)OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(HYDROXYACETYL)-1-METHOXY-, (8S,10S)-